Advertisement
Singapore markets closed
  • Straits Times Index

    3,300.04
    -3.15 (-0.10%)
     
  • S&P 500

    5,190.74
    +10.00 (+0.19%)
     
  • Dow

    38,970.24
    +117.97 (+0.30%)
     
  • Nasdaq

    16,354.22
    +4.98 (+0.03%)
     
  • Bitcoin USD

    63,404.41
    -643.04 (-1.00%)
     
  • CMC Crypto 200

    1,313.84
    -51.29 (-3.76%)
     
  • FTSE 100

    8,318.74
    +105.25 (+1.28%)
     
  • Gold

    2,328.90
    -2.30 (-0.10%)
     
  • Crude Oil

    77.91
    -0.57 (-0.73%)
     
  • 10-Yr Bond

    4.4430
    -0.0460 (-1.02%)
     
  • Nikkei

    38,835.10
    +599.03 (+1.57%)
     
  • Hang Seng

    18,479.37
    -98.93 (-0.53%)
     
  • FTSE Bursa Malaysia

    1,605.68
    +8.29 (+0.52%)
     
  • Jakarta Composite Index

    7,123.61
    -12.28 (-0.17%)
     
  • PSE Index

    6,618.58
    -33.91 (-0.51%)
     

Is This Dividend King a Buy for Income Investors?

Is This Dividend King a Buy for Income Investors?

No matter which way the market goes, the payouts of companies with decades of dividend growth behind them tend to go in one direction: up. Abbott Laboratories' (NYSE: ABT) 50-year dividend growth streak makes it one of just 43 Dividend Kings. With 113,000 employees and a presence in more than 160 countries, Abbott is among the largest healthcare companies in the world.